BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28317533)

  • 1. Genetics of Vitiligo.
    Spritz RA; Andersen GH
    Dermatol Clin; 2017 Apr; 35(2):245-255. PubMed ID: 28317533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the genetics of generalized vitiligo.
    Spritz RA
    J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NALP1 in vitiligo-associated multiple autoimmune disease.
    Jin Y; Mailloux CM; Gowan K; Riccardi SL; LaBerge G; Bennett DC; Fain PR; Spritz RA
    N Engl J Med; 2007 Mar; 356(12):1216-25. PubMed ID: 17377159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
    LaBerge GS; Bennett DC; Fain PR; Spritz RA
    J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).
    Jin Y; Riccardi SL; Gowan K; Fain PR; Spritz RA
    J Invest Dermatol; 2010 Mar; 130(3):774-83. PubMed ID: 19727120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
    Alkhateeb A; Qarqaz F
    Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern genetics, ancient defenses, and potential therapies.
    Gregersen PK
    N Engl J Med; 2007 Mar; 356(12):1263-6. PubMed ID: 17377166
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.
    Dwivedi M; Laddha NC; Begum R
    Adv Exp Med Biol; 2022; 1367():61-103. PubMed ID: 35286692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.
    Jin Y; Birlea SA; Fain PR; Spritz RA
    J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris.
    Strömberg S; Björklund MG; Asplund A; Rimini R; Lundeberg J; Nilsson P; Pontén F; Olsson MJ
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):162-71. PubMed ID: 18426409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genetic Basis of Vitiligo.
    Spritz RA; Santorico SA
    J Invest Dermatol; 2021 Feb; 141(2):265-273. PubMed ID: 32778407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.
    Spritz RA
    J Invest Dermatol; 2012 Feb; 132(2):268-73. PubMed ID: 21993561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
    Jin Y; Andersen G; Yorgov D; Ferrara TM; Ben S; Brownson KM; Holland PJ; Birlea SA; Siebert J; Hartmann A; Lienert A; van Geel N; Lambert J; Luiten RM; Wolkerstorfer A; Wietze van der Veen JP; Bennett DC; Taïeb A; Ezzedine K; Kemp EH; Gawkrodger DJ; Weetman AP; Kõks S; Prans E; Kingo K; Karelson M; Wallace MR; McCormack WT; Overbeck A; Moretti S; Colucci R; Picardo M; Silverberg NB; Olsson M; Valle Y; Korobko I; Böhm M; Lim HW; Hamzavi I; Zhou L; Mi QS; Fain PR; Santorico SA; Spritz RA
    Nat Genet; 2016 Nov; 48(11):1418-1424. PubMed ID: 27723757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic architecture of vitiligo.
    Roberts GHL; Santorico SA; Spritz RA
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):8-15. PubMed ID: 31743585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.